IMAX CORP (IMAX) Stock Fundamental Analysis

NYSE:IMAX • CA45245E1097

37.245 USD
+0.72 (+1.99%)
Last: Feb 26, 2026, 09:35 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, IMAX scores 5 out of 10 in our fundamental rating. IMAX was compared to 80 industry peers in the Entertainment industry. While IMAX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. IMAX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year IMAX was profitable.
  • IMAX had a positive operating cash flow in the past year.
  • In multiple years IMAX reported negative net income over the last 5 years.
  • IMAX had a positive operating cash flow in 4 of the past 5 years.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.45%, IMAX belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
  • IMAX has a Return On Equity of 11.31%. This is amongst the best in the industry. IMAX outperforms 85.00% of its industry peers.
  • The Return On Invested Capital of IMAX (7.73%) is better than 86.25% of its industry peers.
  • IMAX had an Average Return On Invested Capital over the past 3 years of 4.23%. This is below the industry average of 7.68%.
  • The 3 year average ROIC (4.23%) for IMAX is below the current ROIC(7.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.47%, IMAX belongs to the top of the industry, outperforming 86.25% of the companies in the same industry.
  • In the last couple of years the Profit Margin of IMAX has declined.
  • IMAX has a Operating Margin of 19.91%. This is amongst the best in the industry. IMAX outperforms 91.25% of its industry peers.
  • In the last couple of years the Operating Margin of IMAX has declined.
  • Looking at the Gross Margin, with a value of 58.89%, IMAX is in the better half of the industry, outperforming 66.25% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMAX is destroying value.
  • IMAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.75 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • IMAX has a Altman-Z score of 2.75. This is in the better half of the industry: IMAX outperforms 77.50% of its industry peers.
  • The Debt to FCF ratio of IMAX is 2.85, which is a good value as it means it would take IMAX, 2.85 years of fcf income to pay off all of its debts.
  • IMAX has a Debt to FCF ratio of 2.85. This is amongst the best in the industry. IMAX outperforms 81.25% of its industry peers.
  • IMAX has a Debt/Equity ratio of 0.74. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.74, IMAX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.75
ROIC/WACC0.84
WACC9.16%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.47 indicates that IMAX has no problem at all paying its short term obligations.
  • The Current ratio of IMAX (2.47) is better than 80.00% of its industry peers.
  • A Quick Ratio of 2.12 indicates that IMAX has no problem at all paying its short term obligations.
  • IMAX has a better Quick ratio (2.12) than 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for IMAX have decreased by -9.47% in the last year.
  • Measured over the past years, IMAX shows a very strong growth in Earnings Per Share. The EPS has been growing by 130.75% on average per year.
EPS 1Y (TTM)-9.47%
EPS 3Y130.75%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 30.65% on average over the next years. This is a very strong growth
  • IMAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.66% yearly.
EPS Next Y92.39%
EPS Next 2Y48.35%
EPS Next 3Y34.9%
EPS Next 5Y30.65%
Revenue Next Year9.01%
Revenue Next 2Y8.22%
Revenue Next 3Y4.66%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 43.31, which means the current valuation is very expensive for IMAX.
  • 77.50% of the companies in the same industry are more expensive than IMAX, based on the Price/Earnings ratio.
  • IMAX is valuated expensively when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 22.51, the valuation of IMAX can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, IMAX is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • IMAX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.03.
Industry RankSector Rank
PE 43.31
Fwd PE 22.51
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 70.00% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 83.75% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.2
EV/EBITDA 15.32
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IMAX has a very decent profitability rating, which may justify a higher PE ratio.
  • IMAX's earnings are expected to grow with 34.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y48.35%
EPS Next 3Y34.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMAX CORP

NYSE:IMAX (2/26/2026, 9:35:02 AM)

37.245

+0.72 (+1.99%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners93%
Inst Owner Change-4.14%
Ins Owners19.21%
Ins Owner Change-0.2%
Market Cap2.00B
Revenue(TTM)N/A
Net Income(TTM)39.55M
Analysts82.22
Price Target45.22 (21.41%)
Short Float %14.09%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)1.72%
PT rev (3m)17.7%
EPS NQ rev (1m)-0.86%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.6%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 43.31
Fwd PE 22.51
P/S 5.31
P/FCF 22.2
P/OCF 18.35
P/B 5.73
P/tB 7.97
EV/EBITDA 15.32
EPS(TTM)0.86
EY2.31%
EPS(NY)1.65
Fwd EY4.44%
FCF(TTM)1.68
FCFY4.5%
OCF(TTM)2.03
OCFY5.45%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.47
PEG (5Y)N/A
Graham Number11.21
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.75
F-Score8
WACC9.16%
ROIC/WACC0.84
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.47%
EPS 3Y130.75%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y92.39%
EPS Next 2Y48.35%
EPS Next 3Y34.9%
EPS Next 5Y30.65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9.01%
Revenue Next 2Y8.22%
Revenue Next 3Y4.66%
Revenue Next 5YN/A
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year255.09%
EBIT Next 3Y64.22%
EBIT Next 5Y38.42%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

Can you provide the ChartMill fundamental rating for IMAX CORP?

ChartMill assigns a fundamental rating of 6 / 10 to IMAX.


Can you provide the valuation status for IMAX CORP?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 7 / 10.


What is the earnings growth outlook for IMAX CORP?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 92.39% in the next year.